Deals & Cases

10 of 591 results found.
05/22/2020

On May 20, 2020, Invision has announced the sale of Vantage Education AG (Vantage) to a group of Swiss investors.

On May 20, 2020, Invision has announced the sale of Vantage Education AG (Vantage) to a group of Swiss investors. Vantage, one of the leading providers of education and training in Switzerland, will remain independent and will continue to be led by the existing management team.


Homburger acted as legal advisor to the lead investor in connection with the acquisition of Vantage.


The Homburger team was led by partner Frank Gerhard (Corporate | M&A) and included partners Reto Heuberger and Stefan Oesterhelt (both Tax) as well as associate Guy Deillon (Corporate | M&A).

Read more
05/20/2020

On May 14, 2020, Credit Suisse AG (Credit Suisse) launched, and on May 18, 2020 successfully completed, the issuance of (i) EUR 1.5 bn aggregate principal amount of floating rate senior notes due May 2022, and (ii) EUR 500 m aggregate principal amount of 0.450% fixed rate senior notes due May 2025, in each case under Credit Suisse's Euro Medium Term Note (EMTN) Programme.

On May 14, 2020, Credit Suisse AG (Credit Suisse) launched, and on May 18, 2020 successfully completed, the issuance of (i) EUR 1.5 bn aggregate principal amount of floating rate senior notes due May 2022, and (ii) EUR 500 m aggregate principal amount of 0.450% fixed rate senior notes due May 2025, in each case under Credit Suisse's Euro Medium Term Note (EMTN) Programme. The fixed rate senior notes constitute "green bonds", with the net proceeds therefrom to be allocated to projects and assets in accordance with Credit Suisse's green finance framework.


Homburger advised Credit Suisse with respect to all aspects of Swiss law. The Homburger team was led by partner René Bösch (Capital Markets) and included partners Benjamin Leisinger (Capital Markets) and Dieter Grünblatt (Tax), as well as counsel Lee Saladino (Capital Markets) and associate Olivier Baum (Capital Markets).

Read more
05/20/2020

On April 24, 2020, ADC Therapeutics SA (NYSE: ADCT) entered into a USD 115 m credit facility for senior secured convertible loans entered into with funds affiliated with Deerfield Management Company, L.P.

On April 24, 2020, ADC Therapeutics SA (NYSE: ADCT) entered into a USD 115 m credit facility for senior secured convertible loans entered into with funds affiliated with Deerfield Management Company, L.P. On May 19, 2020, the initial disbursement of such convertible term loan in the amount of USD 65 m successfully took place. ADCT is a late clinical-stage oncology-focused biotechnology company headquartered in the Lausanne area that went public on the New York Stock Exchange on May 15, 2020.


The Homburger team was led by partner Dieter Gericke (Corporate | M&A) and included partners Benjamin Leisinger (Banking and Finance) and Stefan Oesterhelt (Tax) as well as associates Daniel Häusermann, Anna Peter, Estelle Piccard (all Corporate | M&A), Alessandra Mengotti and Pierina Janett-Seiler (both Banking and Finance).

Read more
05/19/2020

On May 18, 2020, Nice & Green SA (N&G) and WISeKey International Holding Ltd (WISeKey) entered into an investment agreement regarding N&G's investment of up to CHF 10 m in WISeKey.

On May 18, 2020, Nice & Green SA (N&G) and WISeKey International Holding Ltd (WISeKey) entered into an investment agreement regarding N&G's investment of up to CHF 10 m in WISeKey. The investment is made on the basis of an equity-linked debt instrument issued by WISeKey consisting of convertible notes issued in twenty-five tranches to be drawn over twenty-four months against issuance of convertible notes. The convertible notes are mandatorily convertible into equity at the discretion of N&G within a period of 12 months after their issuance, with a conversion rate of 95% of the lowest volume-weighted average price during the ten trading days preceding the conversion date.


Based in Nyon, Switzerland, N&G is a private company which specializes in financing solutions tailored to the requirements of listed growth companies in the biotech and cleantech industries.


Homburger acts as legal advisor to N&G in connection with the investment agreement. The Homburger team is led by partner Frank Gerhard and included associate Nicola Togni (both Corporate | M&A).


Read more
05/18/2020

On May 15, 2020, ADC Therapeutics SA listed its shares on the New York Stock Exchange (ticker symbol ADCT).

On May 15, 2020, ADC Therapeutics SA listed its shares on the New York Stock Exchange (ticker symbol ADCT). ADCT is a late clinical-stage oncology-focused biotechnology company pioneering the development and commercialization of antibody drug conjugates. Through its IPO, at USD 19 per share, ADCT raises gross proceeds of USD 267 m including greenshoe. At market close on the first day of trading, ADCT had a market capitalization of USD 2.1 bn.


ADCT is the first Swiss company to go public in 2020.


Homburger advises ADC Therapeutics SA in this matter. The Homburger team is led by partner Dieter Gericke (Corporate | M&A) and includes partners Reto Heuberger and Stefan Oesterhelt (both Tax), Benjamin Leisinger (Banking and Finance), as well as associates Daniel Häusermann, Estelle Piccard (both Corporate | M&A), Olivier Baum (Banking and Finance), Manuel Dubach (Tax) and junior associate Oliver Kneubühl (Corporate | M&A).

Read more
05/14/2020

On May 13, 2020, UBS AG (UBS), acting through its London branch, successfully completed its issuance of CHF 340,000,000 in aggregate principal amount of 0.170 per cent. Notes due May 2022 under its Euro Note Programme.

On May 13, 2020, UBS AG (UBS), acting through its London branch, successfully completed its issuance of CHF 340,000,000 in aggregate principal amount of 0.170 per cent. Notes due May 2022 under its Euro Note Programme.


The Notes have been provisionally admitted to trading, and application has been made for admission to trading and listing of the Notes, on the SIX Swiss Exchange. The Notes are Swiss law-governed.


Homburger advised UBS with respect to all transactional aspects of Swiss law. The Homburger team included partners Benedikt Maurenbrecher (Banking and Finance | Capital Markets) and Stefan Oesterhelt (Tax), as well as counsel Lee Saladino (Banking and Finance | Capital Markets).

Read more
05/08/2020

Henkel AG & Co. issued CHF 330 m Bonds. Deutsche Bank Aktiengesellschaft, acting through Deutsche Bank AG Zurich Branch acted as Lead Manager.

Henkel AG & Co. issued CHF 330 m Bonds. Deutsche Bank Aktiengesellschaft, acting through Deutsche Bank AG Zurich Branch acted as Lead Manager. The Bonds will be listed on the SIX Swiss Exchange.


Homburger advised Deutsche Bank AG Zurich Branch. The Homburger team was led by counsel Eduard De Zordi (Banking and Finance | Capital Markets) and included partner Stefan Oesterhelt (Tax) and paralegal Ganna Goncharova (Banking and Finance).

Read more
05/06/2020

On May 4, 2020, Quintet Private Bank (Europe) S.A. (formerly: KBL European Private Bankers S.A.) announced that, after the receipt of all required regulatory approvals, it completed the acquisition of Bank am Bellevue Ltd (now rebranded to Quintet Private Bank (Switzerland) Ltd), the wealth management business of the independent Swiss financial boutique Bellevue Group AG (SWX: BBN).

On May 4, 2020, Quintet Private Bank (Europe) S.A. (formerly: KBL European Private Bankers S.A.) announced that, after the receipt of all required regulatory approvals, it completed the acquisition of Bank am Bellevue Ltd (now rebranded to Quintet Private Bank (Switzerland) Ltd), the wealth management business of the independent Swiss financial boutique Bellevue Group AG (SWX: BBN). The deal closed on April 30, 2020.


Homburger advised Quintet Private Bank (Europe) S.A. on all Swiss law aspects of the transaction. The Homburger team was lead by partner Daniel Hasler (Corporate | M&A) and included partners Benjamin Leisinger (Banking and Finance), Luca Dal Molin and Gregor Bühler (both IP | IT), associates Nina Hagmann (Corporate | M&A), Alexander Wherlock (Banking and Finance), Nina Rabaeus and Regula Fehlmann (both Employment and Executive Compensation), and junior associates Michael Lüchinger and Gregor Schifferle (both Corporate | M&A).

Read more
05/06/2020

On April 20, 2020, BD announced that it has completed the acquisition of Straub Medical AG, a privately-held company that develops and sells medical atherectomy and thrombectomy devices that treat PAD and Venous disease.

On April 20, 2020, BD announced that it has completed the acquisition of Straub Medical AG, a privately-held company that develops and sells medical atherectomy and thrombectomy devices that treat PAD and Venous disease. BD welcomes more than 80 new associates who add valuable experience and expertise as well as key technologies.


This acquisition allows BD to immediately deliver advanced technologies in both atherectomy and thrombectomy and further enhances BD’s already strong portfolio of drug-coated, angio-plasty, and scoring balloons, stents, stent grafts, and CTO crossing products for the treatment of PAD and Venous disease.


The Homburger team advising BD in this transaction was led by partners Daniel Daeniker and Daniel Hasler and associate Karin Mattle (all Corporate | M&A) and included partner Stefan Oesterhelt and associate Marc Vogelsang (both Tax), Mirko Stiefel and junior associate Therry Lehmann (both Corporate | M&A), partner Luca Dal Molin and associate Katrina Frame (both IP | IT), partner Richard Stäuber and associate Sabrina Zimmermann (both Competition | Regulatory), partner Katrin Ivell (Compliance) and partner Claudia Suter (Private Clients).


Read more
05/05/2020

On April 21, 2020, UBS AG (UBS), acting through its London branch, successfully completed its issuance of USD 2.5 bn in aggregate principal amount of 1.75 per cent. Notes due 2022 and EUR 2 bn in aggregate principal amount of 0.750 per cent. Notes due 2023 under its Euro Note Programme.

On April 21, 2020, UBS AG (UBS), acting through its London branch, successfully completed its issuance of USD 2.5 bn in aggregate principal amount of 1.75 per cent. Notes due 2022 and EUR 2 bn in aggregate principal amount of 0.750 per cent. Notes due 2023 under its Euro Note Programme.


Homburger advised UBS with respect to all transactional aspects of Swiss law. The Homburger team included partners Benedikt Maurenbrecher (Banking and Finance | Capital Markets) and Stefan Oesterhelt (Tax), as well as counsel Lee Saladino and associate Olivier Baum (both Banking and Finance | Capital Markets).

Read more